Screening and identification of potential MERS-CoV papain-like protease (PLpro) inhibitors; Steady-state kinetic and Molecular dynamic studies

MERS-CoV belongs to the coronavirus group. Recent years have seen a rash of coronavirus epidemics. In June 2012, MERS-CoV was discovered in the Kingdom of Saudi Arabia, with 2,591 MERSA cases confirmed by lab tests by the end of August 2022 and 894 deaths at a case-fatality ratio (CFR) of 34.5% docu...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Saudi Pharmaceutical Journal
المؤلفون الرئيسيون:	Mohammed Ali Dahhas, Hamad M. Alkahtani, Ajamaluddin Malik, Abdulrahman A Almehizia, Ahmed H. Bakheit, Siddique Akber Ansar, Abdullah S. AlAbdulkarim, Lamees S.Alrasheed, Mohammad A. Alsenaidy
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Springer 2023-02-01
الموضوعات:	MERS-CoV PLpro Inhibitors Papain-like protease Drug Design Drug Discovery Inhibitors Nonstructural proteins
الوصول للمادة أونلاين:	http://www.sciencedirect.com/science/article/pii/S1319016422003061